SBWire

Compounding is the process by which different medications are mixed together to form a single dosage, following a doctor's prescription and customized to the individual patient. Rox San pharmacy offers compounding services to their customers as part of their dedication to providing superior customer services in all aspects of pharmaceutical services.

Global Markets Direct's, 'Bacillus Anthracis Infections - Pipeline Review, H2 2014', provides an overview of the Bacillus Anthracis Infections's therapeutic pipeline.

Global Markets Direct's, 'Contraception - Pipeline Review, H2 2014', provides an overview of the Contraception's therapeutic pipeline.

Global Markets Direct's, 'EyeGene, Inc. - Product Pipeline Review - 2014', provides an overview of the EyeGene, Inc.'s pharmaceutical research and development focus.

Global Markets Direct's, 'Connexios Life Sciences Pvt. Ltd. - Product Pipeline Review - 2014', provides an overview of the Connexios Life Sciences Pvt. Ltd.'s pharmaceutical research and development focus.

Global Markets Direct's, 'Myocarditis - Pipeline Review, H2 2014', provides an overview of the Myocarditis's therapeutic pipeline.

The pharmaceutical industry is one that seems to be in a permanent state of controversy. Being both a massive force for good and one of the most profitable industries in the world, it is in a constant state of dissonance between what it values most. Unfortunately, the friction between these values can create unnecessary or dangerous drugs and medical devices that can have serious side effects and even worse consequences for those using them. Drug Watcher is a website dedicated to keeping a handle on the controversies as they occur and develop, and has just created a new area for Medical Device law suits.

Global Markets Direct's, 'Verastem, Inc. - Product Pipeline Review - 2014', provides an overview of the Verastem, Inc.'s pharmaceutical research and development focus.

Global Markets Direct's, 'Sepsis - Pipeline Review, H2 2014', provides an overview of the Sepsis's therapeutic pipeline.

Global Markets Direct's, 'Eiger BioPharmaceuticals, Inc. - Product Pipeline Review - 2014', provides an overview of the Eiger BioPharmaceuticals, Inc.'s pharmaceutical research and development focus.

Global Markets Direct's, 'Infectitious Diarrhea - Pipeline Review, H2 2014', provides an overview of the Infectitious Diarrhea's therapeutic pipeline.

Global Markets Direct's, 'Angion Biomedica Corp. - Product Pipeline Review - 2014', provides an overview of the Angion Biomedica Corp.'s pharmaceutical research and development focus.

Global Markets Direct's, 'Bioversys AG - Product Pipeline Review - 2014', provides an overview of the Bioversys AG's pharmaceutical research and development focus.

Global Markets Direct's, 'Pharming Group N.V. - Product Pipeline Review - 2014', provides an overview of the Pharming Group N.V.'s pharmaceutical research and development focus.

Global Markets Direct's, 'Retrophin, LLC - Product Pipeline Review - 2014', provides an overview of the Retrophin, LLC's pharmaceutical research and development focus.

Global Markets Direct's, 'Laila Pharmaceuticals Pvt. Ltd. - Product Pipeline Review - 2014', provides an overview of the Laila Pharmaceuticals Pvt. Ltd.'s pharmaceutical research and development focus.

Global Markets Direct's, 'Tetra Discovery Partners LLC - Product Pipeline Review - 2014', provides an overview of the Tetra Discovery Partners LLC's pharmaceutical research and development focus.

Global Markets Direct's, 'Male Infertility - Pipeline Review, H2 2014', provides an overview of the Male Infertility's therapeutic pipeline.

GlobalData's clinical trial report, "Peanut Allergy Global Clinical Trials Review, H2, 2014" provides data on the Peanut Allergy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Peanut Allergy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Peanut Allergy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

GlobalData's clinical trial report, "Lupus Erythematosus Global Clinical Trials Review, H2, 2014" provides data on the Lupus Erythematosus clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Lupus Erythematosus. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Lupus Erythematosus. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

GlobalData's clinical trial report, "Type I hypersensitivity Global Clinical Trials Review, H2, 2014" provides data on the Type I hypersensitivity clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Type I hypersensitivity. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Type I hypersensitivity. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Initial Phase III data released by Portola Pharmaceuticals last week appears to have nudged its recombinant Factor Xa antidote andexanet alfa closer to market. The product is designed to be used in patients who have received therapy with a Factor Xa inhibitor, but whom subsequently need the anticoagulant action to be reversed due to bleeding or the requirement for surgery.

Global Markets Direct's, 'Integrated BioTherapeutics, Inc. - Product Pipeline Review - 2014', provides an overview of the Integrated BioTherapeutics, Inc.'s pharmaceutical research and development focus.

Global Markets Direct's, 'High Triglyceridemia - Pipeline Review, H2 2014', provides an overview of the High Triglyceridemia's therapeutic pipeline.

Rose Bengal has been around for decades starting as a way to dye wool. Originally used in medicine as a stain for ophthalmologists, it has a solid safety record going back to the 1930s. Recently, oncologists have examined its efficacy against cancer, specifically melanoma.